Sign in

NCT07814040Completed

Play Based Approach Among Autism

Effectiveness of the B.A.S.I.C.S. Framework as a Multimodal Play-Based Intervention for Children With Autism Spectrum Disorder: A Retrospective Cohort Study

Source: ClinicalTrials.gov · Last updated 10 Sept 2026

Brief summary (registry, in English)

This pilot study evaluates the effectiveness of the B.A.S.I.C.S. framework, a multimodal play-based intervention designed for children with autism spectrum disorder (ASD). The framework integrates balance, autonomy, social interaction, cognition, and self-reliance through structured, play-based therapeutic activities. The intervention combines motor, sensory, cognitive, communication, and peer-based activities within a therapeutic setting. Children with ASD aged 6-12 years who met the predefined eligibility criteria participated in the intervention. Participants received 45-minute multimodal play therapy sessions three times per week for six weeks. Activities were individualized and progressively graded according to each child's tolerance and performance. The effectiveness of the intervention was evaluated by comparing pre-intervention and post-intervention scores on the WeeFIM (Functional Independence Measure for Children) and the Paediatric Balance Scale. The primary purpose was to determine whether participation in the B.A.S.I.C.S. framework was associated with improvements in functional independence and balance among children with ASD. This study provides preliminary evidence regarding the potential effectiveness of a structured multimodal play-based approach that integrates motor, sensory, cognitive, and social components to support functional outcomes in children with ASD.

Status (registry)
Completed
Study type
Interventional
Enrollment
120 (actual)
First submitted
28 Aug 2026
Start date
3 Jan 2026
Primary completion date
30 Jul 2026
Lead sponsor
Saveetha University
Diseases
Autism
NCT number
NCT07814040

What you commit to

  • Study type: Interventional
  • Participants enrolled: 120
  • From 3 Jan 2026 to the primary completion date, 30 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Neurological disorders
  • Severe visual impairment
  • Severe hearing impairment

Other

  • ASD associated with moderate-to-severe intellectual disability
  • Musculoskeletal deformities

Who the study is looking for

  • Children diagnosed with Autism Spectrum Disorder (ASD) according to DSM-5 criteria
  • Age 6-12 years
  • Both genders
  • Able to understand simple commands
  • Mini-Mental State Examination (MMSE) score \>24

Age in the registry: 6 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Saveetha Medical College and Hospital
Coordinator of this site? Confirm its status
ChennaiIndiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.